Advisory Board May 12, 2023

An FDA advisory committee on Wednesday unanimously recommended the agency approve the first over-the-counter (OTC) birth control pill, a move that was praised by many health experts and would significantly expand access to contraception nationwide.

FDA advisory panel endorses OTC birth control

Over two days of deliberation, members of two FDA advisory committees considered whether patients could safely and effectively take the birth control drug Opill without first consulting a healthcare provider.

Opill, which is manufactured by Perrigo’s HRA Pharma, is a progestin-only pill. Progestin is a synthetic version...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
The risk of a bird flu pandemic is rising
Epidemics then and now: Managing loneliness, burnout, and social media toxicity
Patient Portals 4.0: Future of Patient Engagement
AI tool could predict type 2 diabetes 10 years in advance
208 million Americans are classified as obese or overweight, according to new study on 132 data sources

Share This Article